Stockreport

Pfizer's Monthly GLP-1 Push Tests Balance Between Obesity Growth And Dividends [Yahoo! Finance]

Pfizer, Inc.  (PFE) 
Last pfizer, inc. earnings: 4/28 06:45 am Check Earnings Report
PDF Pfizer (NYSE:PFE) reported Phase 2b results for its GLP-1 anti-obesity candidate, PF-08653944, showing potential for a once monthly injection. The company plans more [Read more]